Found 6 matching trials
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
PHASE4Study 165-401 is a Phase 4, open-label study designed to examine the concom...
Location
UCLA Dept. of Human Genetics
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
PHASE2The primary objective of the study is to evaluate the effect of dosing regi...
Location
The Children's Hospital
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
PHASE3This is a Phase 3 open-label randomized controlled study enrolling approxim...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302
N/AA Phase 3 substudy to evaluate executive function in adults with phenylketo...
Location
University of Kentucky Medical Center
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
PHASE3The BMN 165 clinical development program has been designed to demonstrate t...
Location
University of California, San Diego Clinical and Translational Research Institute
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
PHASE3The BMN 165 clinical development program has been designed to demonstrate t...
Location
University of California, Altman Clinical and Translational Research Institute